Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain R K, Alitalo K
Molecular/Cancer Biology Laboratory, Haartman Institute, University of Helsinki, Finland.
Science. 1997 May 30;276(5317):1423-5. doi: 10.1126/science.276.5317.1423.
No growth factors specific for the lymphatic vascular system have yet been described. Vascular endothelial growth factor (VEGF) regulates vascular permeability and angiogenesis, but does not promote lymphangiogenesis. Overexpression of VEGF-C, a ligand of the VEGF receptors VEGFR-3 and VEGFR-2, in the skin of transgenic mice resulted in lymphatic, but not vascular, endothelial proliferation and vessel enlargement. Thus, VEGF-C induces selective hyperplasia of the lymphatic vasculature, which is involved in the draining of interstitial fluid and in immune function, inflammation, and tumor metastasis. VEGF-C may play a role in disorders involving the lymphatic system and may be of potential use in therapeutic lymphangiogenesis.
尚未发现对淋巴管系统具有特异性的生长因子。血管内皮生长因子(VEGF)调节血管通透性和血管生成,但不促进淋巴管生成。VEGF-C是VEGF受体VEGFR-3和VEGFR-2的配体,在转基因小鼠皮肤中过表达会导致淋巴管而非血管的内皮细胞增殖和血管扩张。因此,VEGF-C诱导淋巴管系统选择性增生,这与组织液引流、免疫功能、炎症及肿瘤转移有关。VEGF-C可能在涉及淋巴系统的疾病中发挥作用,并且在治疗性淋巴管生成方面可能具有潜在用途。